Your selection contains 53 outcomes. Edit selection.
Filter publications

    2024

    1. KNIGHT, Andrea, Martin PISKÁČEK, Marie TOMANDLOVÁ, Tereza SLAMEČKOVÁ, Jiřina PROCHÁZKOVÁ, Daniela ŽÁČKOVÁ and Jiří MAYER. Expression of the immune checkpoint inhibitors on gamma-delta T cells in chronic myeloid leukemia patients during TKI therapy. In ESH-iCMLf 26th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy. 2024.
    2. KNIGHT, Andrea, Martin PISKÁČEK, Marie TOMANDLOVÁ, Hana ŠKABRAHOVÁ, Martina ORSULOVA and Michael DOUBEK. Gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia. In UK CLL FORUM 2024, March 8th, 2024. 2024.
    3. JURÁŇ, Vilém, Václav VYBÍHAL, Marek SOVA, Martin SMRČKA, Tomáš KAZDA, Martin PISKÁČEK and Andrea KNIGHT. Harnessing the EphA2 blockade in glioblastoma. In 4th congress on the Eph-ephrin system, Parma, Italy, May 16-17, 2024. 2024.
    4. KNIGHT, Andrea, Martin PISKÁČEK, Marie TOMANDLOVÁ, Hana ŠKABRAHOVÁ, Martina ORSULOVA and Michael DOUBEK. Innate effector gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia. In Cambridge Immunology Forum: New concepts in innate immunity, September 23rd, 2024. 2024.

    2023

    1. VYBÍHAL, Václav, Vilém JURÁŇ, Tomáš KAZDA, Marek SOVA, Pavel FADRUS, Martin SMRČKA, Martin PISKÁČEK and Andrea KNIGHT. Blockade of PD-L1 and B7-H3 checkpoint inhibitor ligands in glioblastoma. In International Cancer Immunotherapy Conference CICON23. 2023.
    2. KNIGHT, Andrea, Martin PISKÁČEK, Michal JURAJDA, Jiřina PROCHÁZKOVÁ, Zdeněk RÁČIL, Daniela ŽÁČKOVÁ and Jiří MAYER. Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia. Cancer immunology, immunotherapy. NEW YORK: SPRINGER, 2023, vol. 72, No 5, p. 1209-1224. ISSN 0340-7004. Available from: https://dx.doi.org/10.1007/s00262-022-03312-3.
    3. KNIGHT, Andrea, Lucie KRISTOVÁ, Tereza SLAMEČKOVÁ, Marie TOMANDLOVÁ, Martin PISKÁČEK and Robert HUDEČEK. Gamma-delta T cells in patients with endometriosis. In 15th World Congress on Endometriosis 3rd-6th May Edinburgh. 2023.
    4. KNIGHT, Andrea, Josef HOUSER, Vilém JURÁŇ, Václav VYBÍHAL, Pavel FADRUS, Martin SMRČKA and Martin PISKÁČEK. Targeting undruggable oncoproteins c-Myc and N-Myc by the 9aaTADs. In Advanced Therapies 2023, 14-15 March 2023, ExCeL, London. 2023.
    5. HOUSER, Josef, Kristína JENDRUCHOVÁ, Andrea KNIGHT and Martin PISKÁČEK. The NFkB activation domain is 14-amino-acid-long variant of the 9aaTAD. The Biochemical journal. LONDON: PORTLAND PRESS LTD, 2023, vol. 480, No 5, p. 297-306. ISSN 0264-6021. Available from: https://dx.doi.org/10.1042/BCJ20220605.

    2022

    1. HŘÍBKOVÁ, Hana, Ondrej SVOBODA, Elis BARTEČKŮ, Jana ZELINKOVÁ, Jana HOŘÍNKOVÁ, Lubica LACINOVA, Martin PISKÁČEK, Břetislav LIPOVÝ, Ivo PROVAZNÍK, Joel C. GLOVER, Tomáš KAŠPÁREK and Yuh-Man SUN. Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients. Frontiers in Cellular Neuroscience. Lausanne, Switzerland: Frontiers, 2022, vol. 16, February 2022, p. 1-16. ISSN 1662-5102. Available from: https://dx.doi.org/10.3389/fncel.2022.830757.
    2. TOLOCHOVA, Petra, Martin PISKÁČEK, Renata HÉŽOVÁ, Elleni MICHU, Ondřej SLABÝ and Andrea KNIGHT. CMV-reactive Vdelta1 gd T cells are equally cytotoxic to CMV-specific ab T cells in HLA-A*02 healthy donors. In 8th International Congenital CMV Conference & 18th International CMV Workshop, 28th March-1st April 2022 Cambridge. 2022.
    3. KNIGHT, Andrea and Martin PISKÁČEK. Cryptic inhibitory regions nearby activation domains. Biochimie. ISSY-LES-MOULINEAUX: Elsevier, 2022, vol. 200, September 2022, p. 19-26. ISSN 0300-9084. Available from: https://dx.doi.org/10.1016/j.biochi.2022.05.004.
    4. TOMANDLOVÁ, Marie, Martin PISKÁČEK, Vilém JURÁŇ, Marek SOVA, Martin SMRČKA, Václav VYBÍHAL, Pavel FADRUS, Tomáš KAZDA and Andrea KNIGHT. Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients. In Brain Tumour Conference 2022, 5-7 September 2022, London. 2022.
    5. JURÁŇ, Vilém, Martin PISKÁČEK, Marie TOMANDLOVÁ, Marek SOVA, Martin SMRČKA, Tomáš KAZDA, Václav VYBÍHAL, Pavel FADRUS and Andrea KNIGHT. Tumor infiltration of gamma-delta T cells in glioblastoma. In 27th Annual Meeting and Education Day of the Society for Neuro-Oncology November 16 - 20, 2022, Tampa Convention Center, Tampa Bay, FL. 2022.

    2021

    1. HUDEČEK, Robert, Barbora KOHLOVÁ, Ingrid SISKOVA, Martin PISKÁČEK and Andrea KNIGHT. Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing. Frontiers in Immunology. Lausanne: Frontiers, 2021, vol. 12, October 2021, p. 1-12. ISSN 1664-3224. Available from: https://dx.doi.org/10.3389/fimmu.2021.752646.
    2. KOHLOVÁ, Barbora, Martin PISKÁČEK, Marie TOMANDLOVÁ, Veronika MOTÚZOVÁ, Vít ZMÁTLO, Vilém JURÁŇ, Marek SOVA, Václav VYBÍHAL, Pavel FADRUS, Tomáš KAZDA and Andrea KNIGHT. Gamma-delta T cells in Glioblastoma patients. In The 9th International γδ T Cell Conference. 2021.
    3. KOHLOVÁ, Barbora, Martin PISKÁČEK, Marie TOMANDLOVÁ, Veronika MOTÚZOVÁ, Vít ZMÁTLO, Vilém JURÁŇ, Marek SOVA, Václav VYBÍHAL, Pavel FADRUS, Tomáš KAZDA and Andrea KNIGHT. Gamma-delta T cells in Glioblastoma patients. In The 9th International γδ T Cell Conference. 2021.
    4. JURÁŇ, Vilém, Barbora KOHLOVÁ, Martin PISKÁČEK, Vít ZMÁTLO, Leonard JAKUBÁČ, Veronika MOTÚZOVÁ, Marie TOMANDLOVÁ, Marek SOVA, Tomáš KAZDA, Václav VYBÍHAL, Pavel FADRUS and Andrea KNIGHT. Infiltration of Gamma-delta T cells into Glioblastoma Tumor. In WFNOS 2022 - the World Federation of Neuro-Oncology Societies (WFNOS), Seoul, South Korea. 2021.
    5. KNIGHT, Andrea, Lucie ŘÍHOVÁ, Romana KRÁLOVÁ, Miroslav PENKA, Zdeněk ADAM, Luděk POUR, Martin PISKÁČEK and Roman HAJEK. Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma. Journal of Clinical Medicine. Basel: MDPI, 2021, vol. 10, No 16, p. 1-11. ISSN 2077-0383. Available from: https://dx.doi.org/10.3390/jcm10163717.
    6. PISKÁČEK, Martin, Tomáš OTAŠEVIČ, Martin REPKO and Andrea KNIGHT. The 9aaTAD Activation Domains in the Yamanaka Transcription Factors Oct4, Sox2, Myc, and Klf4. Stem Cell Reviews and Reports. NEW YORK: SPRINGER, 2021, vol. 17, No 5, p. 1934-1936. ISSN 2629-3269. Available from: https://dx.doi.org/10.1007/s12015-021-10225-8.
    7. KNIGHT, Andrea, Barbora KOHLOVÁ, Martin PISKÁČEK, Vít ZMÁTLO, Marie TOMANDLOVÁ, Marek SOVA, Vilém JURÁŇ, Tomáš KAZDA, Václav VYBÍHAL and Pavel FADRUS. Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme (Role of cytotoxic gamma-delta T cells in therapeutic resistance and recurrence of Glioblastoma Multiforme). In XLV. Brněnské onkologické dny. 2021. ISSN 0862-495X.
    8. KNIGHT, Andrea, Barbora KOHLOVÁ, Martin PISKÁČEK, Vít ZMÁTLO, Marie TOMANDLOVÁ, Marek SOVA, Vilém JURÁŇ, Tomáš KAZDA, Václav VYBÍHAL and Pavel FADRUS. Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme (Role of cytotoxic gamma-delta T cells in therapeutic resistance and recurrence of Glioblastoma Multiforme). In XLV. Brněnské onkologické dny. 2021.
    9. HOFROVÁ, Alena, Petr LOUŠA, Monika KUBÍČKOVÁ, Jozef HRITZ, Tomáš OTAŠEVIČ, Martin REPKO, Andrea KNIGHT and Martin PISKÁČEK. Universal two-point interaction of mediator KIX with 9aaTAD activation domains. Journal of cellular biochemistry. Hoboken (USA): WILEY-BLACKWELL, 2021, vol. 122, No 10, p. 1544-1555. ISSN 0730-2312. Available from: https://dx.doi.org/10.1002/jcb.30075.

    2020

    1. KNIGHT, Andrea. Detekce myeloidních supresorových buněk v nádorovém mikroprostředí. In Odborný seminář I.T.A.-Intertact s.r.o. 2020.
    2. KNIGHT, Andrea, Robert HUDEČEK, Martin PISKÁČEK, Barbora KOHLOVÁ and Ingrid SISKOVÁ. Innate gamma-delta T cells in endometriosis. In 30. sympozium Asistované reprodukce a 19. česko-slovenské konference Reprodukční gynekologie. 2020.
    3. KNIGHT, Andrea, Robert HUDEČEK, Martin PISKÁČEK, Barbora KOHLOVÁ and Ingrid SISKOVÁ. Innate gamma-delta T cells in endometriosis. In 30. sympozium Asistované reprodukce a 19. česko-slovenské konference Reprodukční gynekologie. 2020.
    4. KAZDA, Tomáš, Radek LAKOMÝ, Alexandr POPRACH, Michal HENDRYCH, Andrea KNIGHT and Pavel ŠLAMPA. Multidisciplinární přístup v léčbě gliomů - astrocytomy a oligodendrogliomy (Multidisciplinary approach in the treatment of gliomas - astrocytomas and oligodendrogliomas.). Postgraduální medicína. Praha: Mladá fronta, 2020, vol. 22, No 2, p. 137-142. ISSN 1212-4184.
    5. LAKOMÝ, Radek, Tomáš KAZDA, Iveta SELINGEROVÁ, Alexandr POPRACH, Petr POSPÍŠIL, Renata BELANOVÁ, Pavel FADRUS, Martin SMRČKA, Václav VYBÍHAL, Radim JANČÁLEK, Igor KISS, Katarína MÚČKOVÁ, Michal HENDRYCH, Andrea KNIGHT, Jiří ŠÁNA, Pavel ŠLAMPA and Ondřej SLABÝ. Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable. Diagnostics. Basel: MDPI, 2020, vol. 10, No 9, p. 1-13. ISSN 2075-4418. Available from: https://dx.doi.org/10.3390/diagnostics10090676.
    6. PISKÁČEK, Martin, Marek HAVELKA, Kristína JENDRUCHOVÁ, Andrea KNIGHT and Liam KEEGAN. The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirs. Cellular and molecular life sciences. BASEL: BIRKHAUSER VERLAG AG, 2020, vol. 77, No 9, p. 1793-1810. ISSN 1420-682X. Available from: https://dx.doi.org/10.1007/s00018-019-03251-w.

    2019

    1. PISKÁČEK, Martin, Marek HAVELKA, Kristína JENDRUCHOVÁ and Andrea KNIGHT. Nuclear hormone receptors: Ancient 9aaTAD and evolutionally gained NCoA activation pathways. Journal of steroid biochemistry and molecular biology. Oxford: Pergamon-Elsevier Science, 2019, vol. 187, MAR 2019, p. 118-123. ISSN 0960-0760. Available from: https://dx.doi.org/10.1016/j.jsbmb.2018.11.008.

    2018

    1. FAFÍLEK, Bohumil, Lukáš BÁLEK, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Alexandru NITĂ, Tomáš GREGOR, Iva GUDERNOVÁ, Jitka KŘENOVÁ, S. GHOSH, Martin PISKÁČEK, Lucie JONATOVA, Nicole ČERNOHORSKÁ, J.T. ZIEBA, M. KOSTAS, E.M. HAUGSTEN, J. WESCHE, C. ERNEUX, Lukáš TRANTÍREK, D. KRAKOW and Pavel KREJČÍ. The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases. SCIENCE SIGNALING. WASHINGTON: AMER ASSOC ADVANCEMENT SCIENCE, 2018, vol. 11, No 548, p. 1-14. ISSN 1945-0877. Available from: https://dx.doi.org/10.1126/scisignal.aap8608.
    2. PISKÁČEK, Martin, Romana KRÁLOVÁ, Maria KRCHNIAKOVA, Michael DOUBEK and Andrea KNIGHT. Tumour-reactive gamma-delta T cells targeting the EphA2 receptor in B- cell CLL. In The 8th International γδ T-Cell Conference Bordeaux, France, 7 - 10 June May 2018. 2018.
    3. KNIGHT, Andrea. Vybrané markery nádorových buněk jako terapeutické cíle B-buněčných malignit. In Seminář I.T.A. - Interact s.r.o., Praha, 2018. 2018.

    2017

    1. PISKÁČEK, Martin, Marek HAVELKA, Martina ŘEZÁČOVÁ and Andrea KNIGHT. The 9aaTAD Is Exclusive Activation Domain in Gal4. Plos one. San Francisco: Public Library of Science, 2017, vol. 12, No 1, p. 1-13. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0169261.
    2. KNIGHT, Andrea. Tumour reactive Gamma Delta T Cells in Haematology. In CCIT - Center for Cancer Immune Therapy, Copenhagen, 27th March 2017. 2017.
    3. KNIGHT, Andrea. Turning up the heat on human gamma-delta T cells in malignant disease. In Vyžádaná přednáška na University Bordeaux. 2017.

    2016

    1. KNIGHT, Andrea, Martin PISKÁČEK, Romana KRÁLOVÁ, Mária KRCHNIAKOVÁ, Petra GALLOVÁ, Martin KUBEŠ, Lucie RIHOVA, Pavla VSIANSKA, Rita PACASOVA, Miroslav PENKA, Zdenek ADAM, Ludek POUR, Roman HAJEK and Anna VAŠKŮ. Analysis of anti-tumour and anti-viral reactivities of human gamma-delta T cells. In Gamma Delta Conference 2016. 2016.
    2. KRÁLOVÁ, Romana, Lucie RIHOVA, Pavla VSIANSKA, Mária KRCHNIAKOVÁ, Martin PISKÁČEK, Rita PACASOVA, Miroslav PENKA, Zdenek ADAM, Ludek POUR, Roman HAJEK and Andrea KNIGHT. Analysis of gamma-delta T cells and plasmacytoid dendritic cells in MGUS and Multiple Myeloma patients. In Gamma Delta Conference 2016. 2016.
    3. KRCHNIAKOVÁ, Mária, Lucie RIHOVA, Romana KRÁLOVÁ, Rita PACASOVA, Miroslav PENKA, Zdenek ADAM, Ludek POUR, Roman HAJEK, Martin PISKÁČEK and Andrea KNIGHT. Analysis of the EphA2 Receptor Expression on Malignant Plasma Cells and Plasmacytoid Dendritic Cells in MGUS and Multiple Myeloma Patients. In Gamma Delta Conference 2016. 2016.
    4. KRCHNIAKOVÁ, Mária, Romana KRÁLOVÁ, Martin PISKÁČEK and Andrea KNIGHT. Analýza expresie receptorov EphA1 a EphA2 u nádorových bunkových línií (Analysis of the expression of EphA2 and EphA1 receptors in tumor cell lines). In XXX. Olomoucké hematologické dny. 2016.
    5. KRÁLOVÁ, Romana, Lucie ŘÍHOVÁ, Pavla VŠIANSKÁ, Mária KRCHNIAKOVÁ, Martin PISKÁČEK, Rita PACASOVÁ, Miroslav PENKA, Zdeněk ADAM, Luděk POUR, Roman HÁJEK and Andrea KNIGHT. Buněčná analýza plasmacytoidních dendritických buněk u mnohočetného myelomu (Cellular analysis of plasmacytoid dendritic cells in Multiple Myeloma). In XXX. Olomoucké hematologické dny. 2016.
    6. KNIGHT, Andrea, Pavel NĚMEC, Soňa BRETZOVÁ, Lucie VÁLKOVÁ, Markéta KOLMANOVÁ, Renáta VYTOPILOVÁ, Marek HAVELKA, Pavla VSIANSKA, Lucie RIHOVA, Marta KREJČÍ and Martin PISKÁČEK. Do human B-lymphocytes avoid aging until 60 years? Oncotarget. New York: Impact Journals, 2016, vol. 7, No 28, p. 42873-42880. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.10146.
    7. PISKÁČEK, Martin, Marek HAVELKA, Martina ŘEZÁČOVÁ and Andrea KNIGHT. The 9aaTAD Transactivation Domains: From Gal4 to p53. Plos one. San Francisco: Public Library of Science, 2016, vol. 11, No 9, p. 1-16. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0162842.

    2015

    1. PISKACEK, Martin, Anna VAŠKŮ, Roman HÁJEK and Andrea KNIGHT. Shared structural features of the 9aaTAD family in complex with CBP. Molecular BioSystems. Cambridge: Royal Society of Chemistry, 2015, vol. 11, No 3, p. 844-851. ISSN 1742-206X. Available from: https://dx.doi.org/10.1039/C4MB00672K.

    2014

    1. PRIETO-HINOJOSA, A., Andrea KNIGHT, C. COMPTON, C. GLEESON and P.J. TRAVERS. Reduced thymic output in elite athletes. Brain, Behavior, and Immunity. Orlando, FL, USA: Academic Press, Orlando, FL, 2014. ISSN 0889-1591. Available from: https://dx.doi.org/10.1016/j.bbi.2014.01.004.
    2. KNIGHT, Andrea, Martin PISKACEK, Pavla VŠIANSKÁ, Rita PACASOVÁ and Anna VAŠKŮ. ROLE OF CYTOMEGALOVIRUS SEROPOSITIVITY ON AGEING OF THE INNATE IMMUNE SYSTEM OF GAMMA-DELTA T CELLS IN HEALTHY DONORS. In The Ageing Summit 2014, Londýn. 2014.
    3. KNIGHT, Andrea. Vdelta1 T cells represent a dominant gamma-delta T cell subset in patients with multiple myeloma. In Tumor Immunology Immunotherapy Torino Conference (TIITC). 2014.

    2013

    1. KNIGHT, Andrea, Hilal ARNOUK, William BRITT, G. Yancey GILLESPIE, Gretchen A. CLOOUD, Lualhati HARKINS, Yun SU, Mark W. LOWDELL and Lawrence S. LAMB. CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vdelta1+ gamma-delta T Cells. PLoS One. San Francisco, CA, USA: Public Library of Science, 2013, vol. 8, No 8, p. e68729, 10 pp. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0068729.
    2. KNIGHT, Andrea, Lucie ŘÍHOVÁ, Tamara VARMUŽOVÁ, Pavla VŠIANSKÁ, Martin PISKACEK, Fedor KRYUKOV, S. MACKINNON and Roman HÁJEK. Human Vdelta1 T cells represent a dominant gamma-delta T cell subset in patients with multiple myeloma. In 18th Congress of the European Hematology Association, Stockholm, Sveden. 2013. ISSN 0390-6078.
    3. KNIGHT, Andrea, Pavla VŠIANSKÁ, Martin PISKACEK, Pavel NĚMEC, Luděk POUR, Zdeněk ADAM and Roman HÁJEK. Interactions of plasmacytoid dendritic cells with myeloma plasma cells and gamma/delta T cells in MGUS and multiple myeloma patients. In ESH International Conference on Multiple Myeloma, Dublin, Ireland. 2013.
    4. KNIGHT, Andrea. Investigations of gamma-delta T cells in patients with monoclonal gammopathy. In Seminar to the students of the International PhD Program in Immunopharmacology at the University of Palermo. 2013.
    5. KNIGHT, Andrea, Stephen MACKINNON and Mark W. LOWDELL. Vdelta1 gamma-delta T cell-mediated killing of myeloma cells: a new candidate for immunotherapy. In XIV. International Myeloma Workshop, Kyoto, Japan. 2013. ISSN 2152-2650.

    2012

    1. MUTHU RAJA, Karthick Raja, Lenka KUBICZKOVÁ, Lucie ŘÍHOVÁ, Martin PISKACEK, Pavla VŠIANSKÁ, Renata HÉŽOVÁ, Luděk POUR and Roman HÁJEK. Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairment. Public Library of Science one. San Francisco, CA, USA: Public Library of Science, 2012, vol. 7, No 11, p. 1-10. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0049446.
Display details
Displayed: 20/10/2024 15:52